Status:
COMPLETED
Study of Bleeding With Extended Administration of an Oral Contraceptive
Lead Sponsor:
Warner Chilcott
Conditions:
Contraception
Eligibility:
FEMALE
25-40 years
Phase:
PHASE2
Brief Summary
This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.
Eligibility Criteria
Inclusion
- Healthy women
- Age 25-40
- History of regular cycles
Exclusion
- Current or recent (within 2 months) users of hormonal contraceptives
- Contraindications for use of hormonal contraception
- Conditions which affect the absorption or metabolism of steroid hormones
- BMI \> 35
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00338052
Start Date
June 1 2006
End Date
May 1 2007
Last Update
May 8 2008
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Warner Chilcott Investigational Site
Phoenix, Arizona, United States, 85031
2
Warner Chilcott Investigational Site
Phoenix, Arizona, United States, 85050
3
Warner Chilcott Investigational Site
Tempe, Arizona, United States, 85283
4
Warner Chilcott Investigational Site
Carmichael, California, United States, 95608